Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 180 participants.
Also called NCT03639480
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT03639480
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT03639480. Randomized; quadruple masking; primary purpose treatment. Start 2017-10-13 (actual); primary completion 2018-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia
- Condition
- Hypertension
- Condition
- Hyperlipidemia
- Intervention (Drug)
- Amlodipine 10mg+Valsartan 160mg+Atorvastatin 40mg
- Intervention (Drug)
- Amlodipine 10mg+Valsartan 160mg
- Intervention (Drug)
- Valsartan 160mg+Atorvastatin 40mg
- Lead sponsor
- HK inno.N Corporation
Record details
- Record id
cardio:ct-nct03639480- Content hash
4ddb6af9f463483e44e7cce7799d21ad62d9abf0637ebf4b621af18585b4fa84